Purchases and Sales Made in Q1 2022 in Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN) during Q1 2022. The information is specifically focused on institutions that hold shares of UroGen Pharma Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 16, 2022
Q1 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-4.24K- 7.86% |
$25.1K - $41.3K
|
49.7K
$524K
|
|
May 12, 2022
Q1 2022
|
Citigroup Inc
|
SELL
|
- |
-4.39K- 78.14% |
$26K - $42.7K
|
1.23K
$12.9K
|
|
May 16, 2022
Q1 2022
|
Aquatic Capital Management LLC
Chicago, IL |
SELL
|
- |
-6.41KClosed |
$37.9K - $62.4K
|
0
$0
|
|
May 13, 2022
Q1 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-8.42K- 4.97% |
$49.9K - $81.9K
|
161K
$1.7M
|
|
May 20, 2022
Q1 2022
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-11.9KClosed |
$70.6K - $116K
|
0
$0
|
|
May 12, 2022
Q1 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-14KClosed |
$83.1K - $137K
|
0
$0
|
|
May 09, 2022
Q1 2022
|
Meitav Dash Investments LTD
|
SELL
|
- |
-19.4K- 12.39% |
$115K - $188K
|
137K
$1.44M
|
|
May 16, 2022
Q1 2022
|
Altshuler Shaham LTD
|
SELL
|
- |
-19.7K- 46.35% |
$117K - $192K
|
22.8K
$240K
|
|
May 16, 2022
Q1 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-20.5K- 74.69% |
$121K - $200K
|
6.95K
$73.3K
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-27.3K- 1.58% |
$162K - $266K
|
1.7M
$17.9M
|
|
May 13, 2022
Q1 2022
|
Coastal Bridge Advisors, LLC
|
SELL
|
- |
-36K- 48.65% |
$213K - $350K
|
38K
$401K
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-43.4K- 52.1% |
$257K - $422K
|
39.9K
$420K
|
|
May 16, 2022
Q1 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-238KClosed |
$1.41M - $2.32M
|
0
$0
|
|
May 13, 2022
Q1 2022
|
Zeke Capital Advisors, LLC
Berwyn, PA |
SELL
|
- |
-414K- 69.68% |
$2.45M - $4.02M
|
180K
$1.9M
|